In focus · trending topic

LATAM Adalimumab Market

1 stories · following the connections

Latin America Adalimumab Market to Reach US$1.18 bn by 2023; Rheumatoid Arthritis, Psoriasis Represent Largest Application Segments: Transparency Market Research

By Nasdaq OMXFeb 25, 2016, 10:32 AM UTC